| For: | Yu LC, Li YP, Xin YM, Mao M, Pan YX, Qu YX, Luo ZD, Zhang Y, Zhang X. Application of Fusobacterium nucleatum as a biomarker in gastrointestinal malignancies. World J Gastrointest Oncol 2024; 16(6): 2271-2283 [PMID: 38994170 DOI: 10.4251/wjgo.v16.i6.2271] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v16/i6/2271.htm |
| Number | Citing Articles |
| 1 |
Tyler Halverson, Kannayiram Alagiakrishnan. The Brain-Gut-Microbiome Axis Across the Life Continuum and the Role of Microbes in Maintaining the Balance of Health. Journal of Integrative Neuroscience 2025; 24(8) doi: 10.31083/JIN36616
|
| 2 |
. Advances in Protein Chemistry and Structural Biology 2025; doi: 10.1016/bs.apcsb.2025.10.008
|
| 3 |
Chengxu Guo, Caixia Wang. Microbiota-host metabolism reprogramming in colorectal cancer: from pathogenesis to precision therapies. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1713614
|
| 4 |
Darab Ghadimi, Sophia Blömer, Aysel Şahin Kaya, Sandra Krüger, Christoph Röcken, Heiner Schäfer, Jumpei Uchiyama, Shigenobu Matsuzaki, Wilhelm Bockelmann. Assessing the role of folate syntrophy and folate cross-feeding in the pathobiology of infectious-inflamed milieu caused by Fusobacterium nucleatum. Experimental and Molecular Pathology 2026; 145: 105021 doi: 10.1016/j.yexmp.2025.105021
|
| 5 |
Stanisław Krokosz, Maria Obrycka, Anna Zalewska. Can Salivary Biomarkers Serve as Diagnostic and Prognostic Tools for Early Detection in Patients with Colorectal Cancer? A Systematic Review. Current Issues in Molecular Biology 2025; 47(8): 647 doi: 10.3390/cimb47080647
|
| 6 |
Shriyansh Srivastava, Sachin Kumar. Microbial oncogenesis: the impact of Fusobacterium nucleatum on oral cancer pathways. Medical Oncology 2025; 43(1) doi: 10.1007/s12032-025-03150-0
|
| 7 |
Kateryna Maslova, Magdalena Chechlinska, Irmina Maria Michalek, Lukasz Taraszkiewicz, Paulina Kober, Inga Trulson, Karolina Worf, Sophie Gabriel, Laura Knoblauch, Fiona Campbell, Ian A. Cree, Stefan Holdenrieder, Magdalena Kowalewska. Tumour markers and evidence-based pathology. Tumor Biology 2026; 48 doi: 10.1177/14230380251410478
|
